Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

a study on HIV/AIDS

Summary

Eligibility
for people ages 16-24 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCLA
Dates
study started
study ends around
Principal Investigator
by Matthew Mimiaga, ScD, MPH (ucla)
Headshot of Matthew Mimiaga
Matthew Mimiaga

Description

Summary

The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.

Official Title

Hybrid Type 2 Effectiveness-Implementation Trial of Status Neutral, Integrated Behavioral Activation and Risk Reduction Intervention for Stimulant Use Among Sexually Active Adolescents and Young Adults (Project IMPACT)

Details

IMPACT is a status-neutral intervention that uses behavioral activation (BA) integrated with sexual health (SH) counseling to support stimulant use reduction and safer sex practices for adolescents and young adults. This study will evaluate the effectiveness of IMPACT and determine feasibility of implementing IMPACT for translation into real-world practice using a hybrid effectiveness-implementation design.

The IMPACT intervention includes 10 sessions: 2 sessions of sexual education and counseling, 1 session focused on psychoeducation and reflection around stimulants, 1 session orienting BA and harm reduction strategies, 5 sessions integrating BA, SH, and coping skills, and 1 final session on reviewing progress and planning for the future.

The enhanced Standard of Care (eSOC) group receives two SH counseling sessions only.

Keywords

HIV, Behavioral activation, Intervention, Stimulant use, HIV sexual health counseling, Behavior, Sexual education and counseling, IMPACT, eSOC

Eligibility

You can join if…

Open to people ages 16-24

  • Age 16-24 years, inclusive, at enrollment
  • Self-reports condomless sex while using stimulants (5 hour prior to, or during sex) within the last 4 months; stimulants is defined as crystal methamphetamine, cocaine, and MDMA (e.g., ecstasy, molly)
  • Willing and able to provide written informed consent for study participation
  • Access to a computer/smartphone/tablet that can use video chat (e.g., Zoom or Google Meet)
  • Provide a mailing address where they can receive a package
  • Access to stable internet that they can use for more than 2 hours at a time
  • Have a private place (where no one else can see or hear) where they can complete visits online
  • Reside within the continental U.S.

You CAN'T join if...

  • Unable to provide informed consent due to severe mental or physical illness
  • Concurrent enrollment in another HIV prevention or treatment study (enrollment in a substance treatment program is acceptable)
  • Randomized to IMPACT arm of study prior to March 2025 study pause
  • Non-English-speaking
  • Is currently incarcerated or pending incarceration
  • Is currently pregnant or planning to become pregnant
  • Any other medical condition, medical/behavioral intervention, or other condition that, in the opinion of the Project Lead or designee, could interfere with the safety of participants or staff, adherence to study procedures, or compromise interpretation of study results

Locations

  • University of California, Los Angeles accepting new patients
    Los Angeles California 90095 United States
  • Brown University accepting new patients
    Providence Rhode Island 02912 United States

Lead Scientist at University of California Health

  • Matthew Mimiaga, ScD, MPH (ucla)
    Professor, Epidemiology, Public Health. Authored (or co-authored) 401 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Westat
ID
NCT06444360
Study Type
Interventional
Participants
Expecting 360 study participants
Last Updated
Contact us about this trial